Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The therapeutic effects of intravenous immunoglobulin (IVIG) on the stiff-person syndrome (SPS) have been described exclusively in case reports or open-label studies in terms of clinical outcomes. We investigate whether IVIG improves quality of life (QoL) in the SPS. Six patients with the classic form of SPS completed a generic QoL instrument, the SF-36, and a Visual Analogue Scale (VAS) before treatment as well as 2 weeks after completion of a course of IVIG. There was significant improvement in the SF-36 subscores for pain, social functioning, general mental health, and energy-vitality with treatment. The VAS also improved significantly. We conclude that treatment with IVIG improves QoL in the SPS.

Original publication

DOI

10.1002/mds.10043

Type

Journal article

Journal

Mov Disord

Publication Date

05/2002

Volume

17

Pages

590 - 593

Keywords

Aged, Female, Humans, Immunoglobulins, Intravenous, Male, Middle Aged, Quality of Life, Stiff-Person Syndrome, Surveys and Questionnaires, Time Factors, Treatment Outcome